Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E W Jeffes

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Lymphokine Research|January 1, 1990
Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patientsT Gatanaga, R Lentz, I Masunaka, et al.
Clinical and Experimental Dermatology|June 28, 2008
Cutaneous horn on the fingerL L Aquino, J J Wu, J E Murase, et al.
Lymphokine and Cytokine Research|April 1, 1991
A simple nonisotopic in vitro bioassay for LT and TNF employing sodium fluoride-treated L-929 target cells that detects picogram quantities of LT and TNF and is as sensitive as TNF assays done with ELISA methodologyE W Jeffes, K Schmitz, R Yamamoto, et al.
Journal of Clinical Immunology|July 1, 1987
Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skinB J Averbook, R S Yamamoto, T R Ulich, et al.
Journal of the American Academy of Dermatology|June 26, 2001
Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue lightE W Jeffes, J L McCullough, G D Weinstein, et al.
International Immunopharmacology|May 19, 2001
Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factorQ Dan, H Trinh, C C Williams, et al.
Arthritis and Rheumatism|September 1, 1989
The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serumE W Jeffes, E K Ininns, K L Schmitz, et al.
The Journal of Clinical Investigation|July 1, 1989
Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell linesS S Sung, L K Jung, J A Walters, et al.
Lymphokine and Cytokine Research|April 1, 1991
Therapy of recurrent high-grade gliomas with surgery, autologous mitogen-activated IL-2-stimulated (MAK) killer lymphocytes, and rIL-2: II. Correlation of survival with MAK cell tumor necrosis factor production in vitroE W Jeffes, Y B Beamer, S Jacques, et al.
The Journal of Investigative Dermatology|February 1, 1995
Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexateE W Jeffes, J L McCullough, M R Pittelkow, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Lymphokine Research|January 1, 1990
Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patientsT Gatanaga, R Lentz, I Masunaka, et al.
Clinical and Experimental Dermatology|June 28, 2008
Cutaneous horn on the fingerL L Aquino, J J Wu, J E Murase, et al.
Lymphokine and Cytokine Research|April 1, 1991
A simple nonisotopic in vitro bioassay for LT and TNF employing sodium fluoride-treated L-929 target cells that detects picogram quantities of LT and TNF and is as sensitive as TNF assays done with ELISA methodologyE W Jeffes, K Schmitz, R Yamamoto, et al.
Journal of Clinical Immunology|July 1, 1987
Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skinB J Averbook, R S Yamamoto, T R Ulich, et al.
Journal of the American Academy of Dermatology|June 26, 2001
Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue lightE W Jeffes, J L McCullough, G D Weinstein, et al.
International Immunopharmacology|May 19, 2001
Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factorQ Dan, H Trinh, C C Williams, et al.
Arthritis and Rheumatism|September 1, 1989
The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serumE W Jeffes, E K Ininns, K L Schmitz, et al.
The Journal of Clinical Investigation|July 1, 1989
Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell linesS S Sung, L K Jung, J A Walters, et al.
Lymphokine and Cytokine Research|April 1, 1991
Therapy of recurrent high-grade gliomas with surgery, autologous mitogen-activated IL-2-stimulated (MAK) killer lymphocytes, and rIL-2: II. Correlation of survival with MAK cell tumor necrosis factor production in vitroE W Jeffes, Y B Beamer, S Jacques, et al.
The Journal of Investigative Dermatology|February 1, 1995
Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexateE W Jeffes, J L McCullough, M R Pittelkow, et al.
Pageof 4